This 7% Yielder Could Be a Top AI Play

finance.yahoo.com/news/7-yielder-could-top-ai-210400060.html

Key Points
-
A looming patent cliff in which Pfizer will lose patent exclusivity to a handful of drugs has combined with cratering revenue from COVID-19 treatments to drive Pfizer shares down 50% since 2022.
-
Pfizer has two important catalysts that can help it not only survive but also…

This story appeared on finance.yahoo.com, 2025-11-30 21:04:00.
The Entire Business World on a Single Page. Free to Use →